du-21220 has been researched along with amibegron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosentino, M; Costa, A; Crema, A; D'Angelo, L; De Ponti, F; Frigo, G; Gibelli, G; Girani, M | 1 |
| Bertini, S; Coruzzi, G; Intorre, L; Soldani, G | 1 |
2 other study(ies) available for du-21220 and amibegron
| Article | Year |
|---|---|
Inhibitory effects of SR 58611A on canine colonic motility: evidence for a role of beta 3-adrenoceptors.
Topics: Adrenergic beta-Agonists; Alprenolol; Animals; Atropine; Colon; Dogs; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Heart Rate; Isoproterenol; Receptors, Adrenergic, beta; Ritodrine; Tetrahydronaphthalenes | 1995 |
Effects of beta3-adrenoceptor agonist SR 58611A on gastric acid secretion and histamine release in the dog: comparison with ritodrine.
Topics: Adrenergic beta-Agonists; Anesthesia; Animals; Dogs; Female; Gastric Acid; Histamine Release; Male; Pentagastrin; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Ritodrine; Tetrahydronaphthalenes | 1998 |